| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.570 | 22.882 | 47.946 | 72.688 | 106.676 | 154.528 | 175.813 | 242.464 |
| Total Income - EUR | - | - | 1.570 | 22.882 | 47.946 | 72.688 | 106.676 | 154.528 | 175.813 | 242.667 |
| Total Expenses - EUR | - | - | 1.915 | 14.181 | 13.145 | 14.403 | 29.461 | 34.659 | 29.244 | 31.176 |
| Gross Profit/Loss - EUR | - | - | -346 | 8.701 | 34.801 | 58.285 | 77.215 | 119.869 | 146.569 | 211.491 |
| Net Profit/Loss - EUR | - | - | -362 | 8.472 | 34.321 | 57.558 | 76.149 | 118.324 | 144.811 | 204.367 |
| Employees | - | - | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Tomuromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 27 | 26 | 26 | 35.027 | 31.508 | 29.832 | 28.581 | 26.494 |
| Current Assets | - | - | 1.696 | 10.271 | 37.107 | 66.452 | 79.587 | 102.143 | 123.060 | 210.054 |
| Inventories | - | - | 0 | 0 | 93 | 91 | 89 | 107 | 107 | 106 |
| Receivables | - | - | 0 | 0 | 5.171 | 1.609 | 0 | 100.530 | 121.411 | 208.867 |
| Cash | - | - | 1.696 | 10.271 | 31.843 | 64.752 | 79.498 | 1.506 | 1.542 | 1.102 |
| Shareholders Funds | - | - | -318 | 8.160 | 34.015 | 57.257 | 75.855 | 118.029 | 144.518 | 204.075 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 2.041 | 2.137 | 3.118 | 44.222 | 35.240 | 13.946 | 7.124 | 32.473 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Tomuromed Srl